Sunkkalp Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -98.77%
- Profit Growth 32.86%
- Ebitda -122.98%
- Net Worth -196.92%
- Total Assets -94.06%
About Sunkkalp Pharmachem
Sunkkalp Pharmachem Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2020 (Four years and eight months 5 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ishan Parekh, Radheeka Daftary, and Kirankumar Shah serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397GJ2020PTC113710
-
Company No.
113710
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 May 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sunkkalp Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishan Parekh
|
Director | 02-Apr-2022 | Current |
|
Radheeka Daftary
|
Director | 03-Dec-2020 | Current |
|
Kirankumar Shah
|
Director | Current |
Financial Performance of Sunkkalp Pharmachem.
Sunkkalp Pharmachem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 98.77% decrease. The company also saw a substantial improvement in profitability, with a 32.86% increase in profit. The company's net worth observed a substantial decline by a decrease of 196.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunkkalp Pharmachem?
In 2023, Sunkkalp Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nuvae Healthcare Private LimitedRadheeka Daftary and Kirankumar Shah are mutual person
-
Sunkkalp Creation Private LimitedIshan Parekh is a mutual person
-
Varsha Traders Pvt Ltd
Ishan Parekh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunkkalp Pharmachem?
Sunkkalp Pharmachem has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunkkalp Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunkkalp Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
